Prognostic impact of macrometastasis linear size in sentinel node biopsy for breast carcinoma

AIM: The aim of the present study was to evaluate the risk of axillary non-sentinel lymph-node metastases (ALN) in breast cancer patients presenting macrometastasis (Mac-m) in the sentinel lymph node (SN). MATERIALS AND METHODS: A retrospective series of 1464 breast cancers from patients who underwe...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Foschini Maria P.
Miglio Rossella
Quinn Cecily
Belgio B
Regitnig Peter
Bianchi Simonetta
Nannini Roberto
Buerger Horst
Kaya Handan
Illyés Ildikó
Kulka Janina
Wells Clive A.
De Gaetano J
Lipeniece-Karele I
Cserni Gábor
Dokumentumtípus: Cikk
Megjelent: W. B. Saunders 2017
Sorozat:EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 43 No. 8
doi:10.1016/j.ejso.2017.05.007

mtmt:3235571
Online Access:http://publicatio.bibl.u-szeged.hu/12580
LEADER 02723nab a2200373 i 4500
001 publ12580
005 20200213104401.0
008 171221s2017 hu o 0|| zxx d
022 |a 0748-7983 
024 7 |a 10.1016/j.ejso.2017.05.007  |2 doi 
024 7 |a 3235571  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Foschini Maria P. 
245 1 0 |a Prognostic impact of macrometastasis linear size in sentinel node biopsy for breast carcinoma  |h [elektronikus dokumentum] /  |c  Foschini Maria P. 
260 |a W. B. Saunders  |c 2017 
300 |a 1421-1427 
490 0 |a EUROPEAN JOURNAL OF SURGICAL ONCOLOGY  |v 43 No. 8 
520 3 |a AIM: The aim of the present study was to evaluate the risk of axillary non-sentinel lymph-node metastases (ALN) in breast cancer patients presenting macrometastasis (Mac-m) in the sentinel lymph node (SN). MATERIALS AND METHODS: A retrospective series of 1464 breast cancers from patients who underwent ALN dissection following the diagnosis of Mac-m in the sentinel node (SN) was studied. In all the cases the MAC-m linear size was evaluated and correlated with presence or absence of non-SN ALN metastases. RESULTS: Non-SN metastases were detected in 644\1464 cases (43.98%). The risk of further axillary metastases ranged from 20.2% (37/183) in cases with Mac-m between 2 and 2.9 mm, to 65.3% (262/401) in cases with Mac-m measuring > 10 mm. The risk of non-SN ALN metastases showed a 3% increase, parallel to each mm increment in SN metastasis size. The data evaluated with the receiver operating characteristic (ROC) curve showed that the Mac-m could be subdivided according to a new cut-off of 7 mm. pT1 tumours, with Mac-m < 7 mm had a risk of non-SN ALN metastases of <30%. Furthermore 109/127 of these (85.8%) had 3 or less non-SN ALN -metastases. CONCLUSIONS: The present data give a detailed description on the risk of non-SN ALN involvement, that may be useful in the evaluation of breast cancer patients. It is suggested that a Mac-m size of <7 mm is related to a low residual axillary disease burden in breast cancer patients with small (pT1) tumours. 
700 0 1 |a Miglio Rossella  |e aut 
700 0 1 |a Quinn Cecily  |e aut 
700 0 1 |a Belgio B  |e aut 
700 0 1 |a Regitnig Peter  |e aut 
700 0 1 |a Bianchi Simonetta  |e aut 
700 0 1 |a Nannini Roberto  |e aut 
700 0 1 |a Buerger Horst  |e aut 
700 0 1 |a Kaya Handan  |e aut 
700 0 1 |a Illyés Ildikó  |e aut 
700 0 1 |a Kulka Janina  |e aut 
700 0 1 |a Wells Clive A.  |e aut 
700 0 2 |a De Gaetano J  |e aut 
700 0 2 |a Lipeniece-Karele I  |e aut 
700 0 2 |a Cserni Gábor  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/12580/1/1_s2.0_S0748798317304857_main_u.pdf  |z Dokumentum-elérés